Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody response to mRNA COVID-19 booster in people living with HIV by CD4 T-cell level
TCTR20240708002Completed
- Sponsor
- Thai AIDS Society
- Start
- Apr 2023
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of mRNA COVID-19 vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Thai AIDS Society. Primary endpoint: Antibody response to mRNA COVID-19 booster. Started Apr 2023; status: completed.
02
Drugs
mRNA COVID-19 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20240708002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240708002.